A rapid and sensitive chemiluminescence immunoassay based on magnetic particles for squamous cell carcinoma antigen in human serum

Clinica Chimica Acta

Volumn 412, Issue 17-18, 2011, Pages 1572-1577

  Zhang, Huisheng ^a   Qi, Suwen ^a  

^a SHENZHEN UNIVERSITY   (China)

Author keywords

Chemiluminescence immunoassay; Magnetic particles; Squamous cell carcinoma antigen

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE; MAGNETITE NANOPARTICLE; MONOCLONAL ANTIBODY; N (AMINOBUTYL) N (ETHYLISOLUMINOL); SQUAMOUS CELL CARCINOMA ANTIGEN; UNCLASSIFIED DRUG;

ACCURACY; ANTIBODY BLOOD LEVEL; ANTIBODY LABELING; ARTICLE; AUTOANALYZER; BLOOD ANALYSIS; CHEMOLUMINESCENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DILUTION; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; LIMIT OF DETECTION; LUMINESCENCE IMMUNOASSAY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SENSITIVITY AND SPECIFICITY; SOLID;

ANTIGENS, NEOPLASM; CALIBRATION; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; IMMUNOASSAY; INDICATORS AND REAGENTS; LIMIT OF DETECTION; MAGNETICS; REFERENCE STANDARDS; SERPINS;

EID: 79959297723     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.05.005     Document Type: Article

References (31)

1. Kato H., Morioka H., Aramaki S., Torigoe T. Radioimmunoassay for tumor-antigen of human cervical squamous cell carcinoma. Cell Mol Biol Incl Cyto Enzymol 1979, 25:51-56.
2. Kato H., Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977, 40:1621-1628.
3. Giannelli G., Fransvea E., Trerotoli P., Beaugrand M., Marinosci F., Lupo L., et al. Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients. Clin Chim Acta 2007, 383:147-152.
4. Taniguchi H., Sakagami J., Suzuki N., Hasegawa H., Shinoda M., Tosa M., et al. Adenoendocrine cell carcinoma of the gallbladder clinically mimicking squamous cell carcinoma. Int J Clin Oncol 2009, 14:167-170.
5. Cheah P.L., Liam C.K., Yap S.F., Looi L.M. Squamous cell carcinoma antigen as an adjunct tumour marker in primary carcinoma of the lung. J Clin Pathol 1994, 47:535-537.
6. Sanchez De Cos J., Masa F., de la Cruz J.L., Disdier C., Vergara C. Squamous cell carcinoma antigen (SCC Ag) in the diagnosis and prognosis of lung cancer. Chest 1994, 105:773-776.
7. Ho Y.J., Hsieh J.F., Tasi S.C., Lee J.K., Kao C.H. Tissue polypeptide specific antigen and squamous cell carcinoma antigen for early prediction of recurrence in lung squamous cell carcinoma. Lung 2000, 178:75-80.
8. Torre G.C. SCC antigen in malignant and nonmalignant squamous lesions. Tumour Biol 1998, 19:517-526.
9. Hussein M.M., Ibrahim A.A., Abdella H.M., Montasser I.F., Hassan M.I. Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients. Indian J Cancer 2008, 45:167-172.
10. Micke O., Bruns F., Schafer U., Prott F.J., Willich N. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy. Anticancer Res 2005, 25:1663-1666.
11. Bandoh N., Ogino T., Katayama A., Takahara M., Katada A., Hayashi T., et al. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis. Oncol Rep 2010, 23:933-939.
12. Takahashi H., Iizuka H., Nakashima M., Wada T., Asano K., Ishida-Yamamoto A., et al. RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin. J Dermatol Sci 2001, 26:140-144.
13. Sumiyoshi K., Kuwano H., Watanabe M., Kitamura M., Toh Y., Sugimachi K. HLA-DR antigen expression in squamous epithelial dysplasia and squamous cell carcinoma of the esophagus: an immunohistochemical study. Oncol Rep 1999, 6:301-306.
14. Petrelli N.J., Palmer M., Herrera L., Bhargava A. The utility of squamous cell carcinoma antigen for the follow-up of patients with squamous cell carcinoma of the anal canal. Cancer 1992, 70:35-39.
15. van der Sijde R., de Bruijn H.W., Krans M., Bouma J., Aalders J.G. Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva. Gynecol Oncol 1989, 35:227-232.
16. Staibano S., Mignogna M.D., Lo Muzio L., Di Alberti L., Di Natale E., Lucariello A., et al. Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity. Hum Pathol 1998, 29:1189-1194.
17. Feng X.Y., Li J.H., Li J.Z., Han Z.X., Xing R.D. Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma. Int J Biol Markers 2010, 25:93-98.
18. Hatzakis K.D., Froudarakis M.E., Bouros D., Tzanakis N., Karkavitsas N., Siafakas N.M. Prognostic value of serum tumor markers in patients with lung cancer. Respiration 2002, 69:25-29.
19. Bae S.N., Namkoong S.E., Jung J.K., Kim C.J., Park J.S., Kim J.W., et al. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1997, 64:418-424.
20. Kim Y.T., Yoon B.S., Kim J.W., Kim S.H., Kwon J.Y., Kim J.H. Pretreatment levels of serum squamous cell carcinoma antigen and urine polyamines in women with squamous cell carcinoma of the cervix. Int J Gynaecol Obstet 2005, 91:47-52.
21. Hirakawa M., Nagai Y., Inamine M., Kamiyama K., Ogawa K., Toita T., et al. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy. Gynecol Oncol 2008, 108:126-129.
22. Ghosh S.K., Roland N.J., Kumar A., Tandon S., Lancaster J.L., Jackson S.R., et al. Detection of synchronous lung tumors in patients presenting with squamous cell carcinoma of the head and neck. Head Neck 2009, 31:1563-1570.
23. Erickson J.A., Lu J., Smith J.J., Bornhorst J.A., Grenache D.G., Ashwood E.R. Immunoassay for quantifying squamous cell carcinoma antigen in serum. Clin Chem 2010, 56:1496-1499.
24. Chang J.T., Wong F.H., Liao C.T., Chen I.H., Wang H.M., Cheng A.J. Enzyme immunoassay for serum autoantibody to survivin and its findings in head-and-neck cancer patients. Clin Chem 2004, 50:1261-1264.
25. Koizumi M., Endo K., Nakajima K., Sakahara H., Kawamura Y., Watanabe Y., et al. Fundamental and clinical evaluation of "SCC RIABEAD" kit for immunoradiometric assay of squamous cell carcinoma related antigen. Kaku Igaku 1987, 24:1693-1700.
26. Rodriguez-Orozco A.R., Ruiz-Reyes H., Medina-Serriteno N. Recent applications of chemiluminescence assays in clinical immunology. Mini Rev Med Chem 2010, 10:1393-1400.
27. Xiao Q., Li H., Lin J.M. Development of a highly sensitive magnetic particle-based chemiluminescence enzyme immunoassay for thyroid stimulating hormone and comparison with two other immunoassays. Clin Chim Acta 2010, 411:1151-1153.
28. Li Z.Y., Zhang Q.Y., Zhao L.X., Li Z.J., Hu G.M., Lin J.M., et al. Micro-plate magnetic chemiluminescence immunoassay and its applications in carcinoembryonic antigen analysis. Sci China Chem 2010, 53:812-819.
29. Tian D., Duan C., Wang W., Li N., Zhang H., Cui H., et al. Sandwich-type electrochemiluminescence immunosensor based on N-(aminobutyl)-N-ethylisoluminol labeling and gold nanoparticle amplification. Talanta 2009, 78:399-404.
30. Wang X., Zhang Q.Y., Li Z.J., Ying X.T., Lin J.M. Development of high-performance magnetic chemiluminescence enzyme immunoassay for alpha-fetoprotein (AFP) in human serum. Clin Chim Acta 2008, 393:90-94.
31. Zhang Q., Wang X., Li Z., Lin J.M. Evaluation of alpha-fetoprotein (AFP) in human serum by chemiluminescence enzyme immunoassay with magnetic particles and coated tubes as solid phases. Anal Chim Acta 2009, 631:212-217.